94 related articles for article (PubMed ID: 1461931)
1. Cancer destruction in vivo through disrupted energy metabolism. Part I. The endogenous mechanism of self-destruction within the malignant cell, and the roles of endotoxin, certain hormones and drugs, and active oxygen in causing cellular injury and death.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):169-79. PubMed ID: 1461931
[TBL] [Abstract][Full Text] [Related]
2. Cancer destruction in vivo through disrupted energy metabolism. Part II. Lipid peroxidation and cell death; drug resistance as a consequence of reversible cellular injury.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):181-94. PubMed ID: 1461932
[TBL] [Abstract][Full Text] [Related]
3. Cancer destruction in vivo through disrupted energy metabolism. Part III. Spontaneous drug resistance, selectivity of antineoplastic action, and strategies for intensifying tumor injury.
Jones GR
Physiol Chem Phys Med NMR; 1992; 24(3):195-212. PubMed ID: 1461933
[TBL] [Abstract][Full Text] [Related]
4. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
7. Endogenous and induced oxidative stress in multi-cellular tumour spheroids: implications for improving tumour therapy.
Khaitan D; Dwarakanath BS
Indian J Biochem Biophys; 2009 Feb; 46(1):16-24. PubMed ID: 19374249
[TBL] [Abstract][Full Text] [Related]
8. [Free oxygen radiacals and kidney diseases--part I].
Sakac V; Sakac M
Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
[TBL] [Abstract][Full Text] [Related]
9. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
Denmeade SR; Lin XS; Isaacs JT
Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J; Seki T; Maeda H
Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells.
Khadir A; Verreault J; Averill DA
Arch Biochem Biophys; 1999 Oct; 370(2):163-75. PubMed ID: 10510274
[TBL] [Abstract][Full Text] [Related]
12. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
Taylor BM; Fleming WE; Benjamin CW; Wu Y; Mathews WR; Sun FF
J Pharmacol Exp Ther; 1996 Mar; 276(3):1224-31. PubMed ID: 8786555
[TBL] [Abstract][Full Text] [Related]
14. Targeting of cancer energy metabolism.
Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
[TBL] [Abstract][Full Text] [Related]
15. Cancer therapy at the crossroads: which direction for the future?
Jones GR
Physiol Chem Phys Med NMR; 1991; 23(4):217-20. PubMed ID: 1812501
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.
Cuzzocrea S; Riley DP; Caputi AP; Salvemini D
Pharmacol Rev; 2001 Mar; 53(1):135-59. PubMed ID: 11171943
[TBL] [Abstract][Full Text] [Related]
17. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
Sahnoun Z; Jamoussi K; Zeghal KM
Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
[TBL] [Abstract][Full Text] [Related]
18. Impact of multicellular resistance on the survival of solid tumors, including micrometastases.
Kerbel RS
Invasion Metastasis; 1994-1995; 14(1-6):50-60. PubMed ID: 7657532
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
20. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
